Streetbeat News

Analyst Ratings

ENTA

Enanta Pharmaceuticals reported Q3 financial results, which led to a decrease in its share price. Jefferies also downgraded the stock from Buy to Hold and lowered its price target from $49 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:14 pm

ABNB

Deutsche Bank analyst Lee Horowitz maintains a 'Hold' rating on Airbnb (NASDAQ:ABNB) and raises the price target from $102 to $105.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:09 pm

RNG

Morgan Stanley analyst Meta Marshall has downgraded RingCentral (NYSE:RNG) from Overweight to Equal-Weight and lowered the price target from $49 to $42.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:07 pm

UWMC

UWM Holdings Corporation's stock has been downgraded from Market Outperform to Market Perform by JMP Securities, leading to a decrease in the trading price.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:02 pm

ENB

TD Securities analyst Linda Ezergailis has maintained a 'Buy' rating on Enbridge (NYSE:ENB) but lowered the price target from C$62 to C$58.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:02 pm

SLG

Over the past 3 months, 9 analysts have published their opinion on SL Green Realty (NYSE:SLG) stock. The average price target is $31.89, which is lower than the current price of $36.92. The average price target has increased by 16.86% over the past month.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 5:00 pm

CPB

Campbell Soup (NYSE:CPB) has received mixed analyst ratings in the last quarter, with 9 indifferent, 3 somewhat bearish, and 2 bearish. The average 12-month price target for the company is $49.57, a 5.36% decrease from the previous average of $52.38.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 5:00 pm

SWKS

In the last quarter, Skyworks Solutions (NASDAQ:SWKS) received mostly bullish ratings from analysts. The company has an average 12-month price target of $127.0, which is a 7.63% increase from the previous average price target of $118.00.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 5:00 pm

CCRN

Credit Suisse has maintained its Neutral rating for Cross Country Healthcare (NASDAQ:CCRN) but lowered its price target from $27.00 to $26.00. Cross Country Healthcare's shares are currently trading up 1.89% over the last 24 hours, at $22.61 per share. A move to $26.00 would account for a 14.99% increase from the current share price.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 5:00 pm

APO

Over the past 3 months, 12 analysts have published their opinion on Apollo Global Management (NYSE:APO) stock. The average price target for the stock is $89.42, with a high of $104.00 and a low of $79.00. The average price target has increased by 11.15% over the past month.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 5:00 pm